Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3675154014 | Albuterol (as albuterol sulfate) 8 mg prolonged-release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3675155010 | Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3675157019 | Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4676531000052111 | salbutamol (som salbutamolsulfat) 8 milligram, depåkapsel | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Prolonged-release oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Salbutamol-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Has precise active ingredient | Salbutamol sulfate | true | Inferred relationship | Some | 1 | |
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | har täljarvärde som visar styrka | åtta | false | Inferred relationship | Some | 1 | |
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Salbutamol | true | Inferred relationship | Some | 1 | |
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product containing only salbutamol in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product containing beta-2 adrenergic receptor agonist (product) | false | Inferred relationship | Some | ||
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product containing ethanolamine and/or ethanolamine derivative (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR